Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02426138 · ClinicalTrials.gov registry record · NA

Community Servings: Food as Medicine for Diabetes

A NA study of Diabetes, sponsored by Massachusetts General Hospital.

Completed
Registry status
NA
Development phase
44
Enrollment target
1
Study location

NCT02426138 is a NA study of Diabetes that has completed, run by Massachusetts General Hospital. The registered enrollment target is 44 participants, below the 3,028-participant average among 338 other Diabetes trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02426138, a NA study of Diabetes, has completed, sponsored by Massachusetts General Hospital.

COMPLETED
Registry status
NA
Development phase
44 participants
Enrollment target
1
Study location

Study Summary

Food insecurity, defined as difficulty accessing food owing to cost, affects 1 in 5 diabetes patients. To address this, the investigators are conducting a pilot randomized controlled trial of medically tailored meal delivery (MTM). The pilot study has two specific aims: Aim 1: To determine the effect of receiving MTM on dietary quality for food insecure diabetes patients with hyperglycemia Aim 2: To determine the feasibility and acceptability of the program as a medical intervention and refine the program as needed for testing in larger studies. This study is a crossover randomized controlled pilot trial, where approximately 50 participants, 25 in each arm, will be randomized to receipt of 12 weeks of MTM, to begin immediately, or waitlist control. After 12 weeks, the groups will crossover, with the waitlist control group now receiving 12 weeks of MTM. At baseline, 12 weeks, and 24 weeks, the participants will complete assessments of their dietary quality (HEI score), psychosocial measures such as diabetes distress and food insecurity, along with measures of body mass index, blood pressure, hemoglobin A1c, and lipids.

Conditions Studied

Interventions

  • OTHER Medically Tailored Meal Delivery (MTM)
  • OTHER Usual Care + Choose MyPlate

Study Locations (1)

Massachusetts

  • Massachusetts General Hospital - Boston

Trial Details

FieldValue
Enrollment Target 44 participants
Start Date 2015-04-01
Est. Completion 2017-07-31
Phase NA

Sponsor

Massachusetts General Hospital

2,032 total trials

What the Registry Record Tells You About NCT02426138

The ClinicalTrials.gov registry entry for NCT02426138 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 44 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,028-participant average among 338 other Diabetes trials with a reported enrollment target (99% lower). The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Diabetes appearing as the primary indexed condition, and to 2 interventions - of which Medically Tailored Meal Delivery (MTM) is the first listed.

NCT02426138 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT02426138 about?

NCT02426138 is a clinical study titled "Community Servings: Food as Medicine for Diabetes". Food insecurity, defined as difficulty accessing food owing to cost, affects 1 in 5 diabetes patients. To address this, the investigators are conducting a pilot randomized controlled trial of medically tailored meal delivery (MTM). The pilot study has two specific aims: Aim 1: To determine the effe...

What is the current status of trial NCT02426138?

This trial is currently completed. It is a NA study. The enrollment target is 44 participants. The study started on 2015-04-01. Estimated completion is 2017-07-31.

What conditions does trial NCT02426138 study?

This clinical trial studies the following conditions: Diabetes.

What interventions are being tested in trial NCT02426138?

The interventions under investigation include: Medically Tailored Meal Delivery (MTM) (OTHER), Usual Care + Choose MyPlate (OTHER).

Who is sponsoring clinical trial NCT02426138?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02426138 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Diabetes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.